Journal of Health Politics Policy and Law

Papers
(The median citation count of Journal of Health Politics Policy and Law is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Pandemic Politics: Timing State-Level Social Distancing Responses to COVID-19206
The Emergence of COVID-19 in the US: A Public Health and Political Communication Crisis175
Democracy, Capacity, and Coercion in Pandemic Response: COVID-19 in Comparative Political Perspective98
Racism and the Political Economy of COVID-19: Will We Continue to Resurrect the Past?81
Equitable Pandemic Preparedness and Rapid Response: Lessons from COVID-19 for Pandemic Health Equity49
No Equity without Data Equity: Data Reporting Gaps for Native Hawaiians and Pacific Islanders as Structural Racism37
Health Equity, Social Policy, and Promoting Recovery from COVID-1930
Federalism Complicates the Response to the COVID-19 Health and Economic Crisis: What Can Be Done?29
Lingering Legacies: Public Attitudes about Medicaid Beneficiaries and Work Requirements29
Affordable but Inaccessible? Contraception Deserts in the US States26
Fighting for America's Paradise: The Struggle against Structural Racism15
The Treatment of Disability under Crisis Standards of Care: An Empirical and Normative Analysis of Change over Time during COVID-1914
Who Stays at Home? The Politics of Social Distancing in Brazil, Mexico, and the United States during the COVID-19 Pandemic14
What Is EU Public Health and Why? Explaining the Scope and Organization of Public Health in the European Union13
The Potential and Realized Impact of the Affordable Care Act on Health Equity13
Extending Postpartum Medicaid: State and Federal Policy Options during and after COVID-1912
Who Counts Where? COVID-19 Surveillance in Federal Countries12
Ideological Sorting of Physicians in Both Geography and the Workplace12
Coping with Denialism: How Street-Level Bureaucrats Adapted and Responded to COVID-19 in Tanzania12
Understanding the Anemic Global Response to COVID-1911
Compounding Racialized Vulnerability: COVID-19 in Prisons, Jails, and Migrant Detention Centers10
Pursuing Pharmacoequity: Determinants, Drivers, and Pathways to Progress10
Ten Years of Messaging about the Affordable Care Act in Advertising and News Media: Lessons for Policy and Politics9
The No Surprises Act: A Bipartisan Achievement to Protect Consumers from Unexpected Medical Bills9
The Line between Medicaid and Marketplace: Coverage Effects from Wisconsin's Partial Expansion9
Unsanitized and Unfair: How COVID-19 Bailout Funds Refuel Inequity in the US Health Care System8
Going the Extra Mile? How Provider Network Design Increases Consumer Travel Distance, Particularly for Rural Consumers8
State Policies and Health Disparities between Transgender and Cisgender Adults: Considerations and Challenges Using Population-Based Survey Data8
The Political Economy of Market Power in Pharmaceuticals8
Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement8
A Look Under the Hood: Regulatory Policy Making and the Affordable Care Act8
Factors Affecting State-Level Enforcement of the Federal Mental Health Parity and Addiction Equity Act: A Cross-Case Analysis of Four States8
Introduction to “COVID-19: Politics, Inequalities, and Pandemic”7
The Affordable Care Act's Missing Consensus: Values, Attitudes, and Experiences Associated with Competing Health Reform Preferences7
The Political Realignment of Health: How Partisan Power Shaped Infant Health in the United States, 1915–20176
More Than Words? How Highlighting Target Populations Affects Public Opinion about the Medicaid Program6
Racism, Health, and Politics: Advancing Interdisciplinary Knowledge6
Physician Trust in the News Media and Attitudes toward COVID-196
Americans' View of the Impact of COVID-19: Perspectives on Racial Impacts and Equity6
Inside ILSI: How Coca-Cola, Working through Its Scientific Nonprofit, Created a Global Science of Exercise for Obesity and Got It Embedded in Chinese Policy (1995–2015)6
Disaster Preparedness and Social Justice in a Public Health Emergency6
Technically Accessible, Practically Ineligible: The Effects of Medicaid Expansion Implementation on Chronic Homelessness6
Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States6
When Doctors strike: Making Sense of Professional Organizing in Kenya6
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.6
The Future of State All-Payer Claims Databases6
Regional International Organizations and Health: A Framework for Analysis5
State Policy and Mental Health Outcomes under COVID-195
Termites of Solidarity in the House of Austerity: Undermining Fiscal Governance in the European Union5
A Draconian Law: Examining the Navigation of Coalition Politics and Policy Reform by Health Provider Associations in Karnataka, India5
Policy Responses to the Addiction Crisis5
Negotiating Change: Ideas, Institutions, and Political Actors in Tobacco Control Policy Making in Mauritius5
Authoritarian Regime Legitimacy and Health Care Provision: Survey Evidence from Contemporary China5
Value-Based Insurance Design: Clinically Nuanced Consumer Cost Sharing to Increase the Use of High-Value Medications5
Prescription Drug Priorities under the Biden Administration5
Networked Health Care Governance in the European Union5
Potemkin Protections: Assessing Provider Directory Accuracy and Timely Access for Four Specialties in California5
Health “Brexternalities”: The Brexit Effect on Health and Health Care outside the United Kingdom4
Entrenching Inequity, Eroding Democracy: State Preemption of Local Housing Policy4
Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?4
The Conditional Effects of Health on Voter Turnout4
Introduction to “Subnational COVID-19 Politics and Policy”4
County-Level Segregation and Racial Disparities in COVID-19 Outcomes4
A Mixed-Methods Approach to Understanding the Disconnection between Perceptions of Abortion Acceptability and Support for Roe v. Wade among US Adults4
What Is a “Racial Health Disparity”? Five Analytic Traditions4
How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences4
Health Technology Assessment and Health Care Reimbursement in the European Union: Permissive Dissensus and the Limits of Harmonization through the Backdoor4
A Decade of ACOs in Medicare: Have They Delivered on Their Promise?3
Prospects for Enforcing Prohibitions on Off-Label Drug Promotion after United States v. Caronia: An Analysis of Litigated Cases3
Health Care and the Fate of Social Europe3
“The CDC Won't Let Me Be”: The Opinion Dynamics of Support for CDC Regulatory Authority3
The Rhetorical Transformations and Policy Failures of Prescription Drug Pricing Reform under the Trump Administration3
Introduction to “Recontextualizing Physician Associations: Revisiting Context, Scope, Methodology”3
Trajectories of Professional Authority: A Comparative Study of Medical Associations and Professional Authority Claims3
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i Loophole3
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies3
Self-Sourced Medication Abortion, Physician Authority, and the Contradictions of Abortion Care3
State Courts, State Legislatures, and Setting Abortion Policy3
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature Review3
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies3
International Reference Pricing in the Context of US Drug Policy3
Diminishing Democracy in Health Policy: Partisanship, the Courts, and the End of Health Politics as We Knew It3
How Workers Fared under the ACA3
Mexican-Origin Women's Construction and Navigation of Racialized Identities: Implications for Health Amid Restrictive Immigrant Policies3
Intellectual Property and the Politics of Public Good during COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO3
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits3
History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion3
The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms3
Health Insurance Loss during COVID-19 May Increase Support for Universal Health Coverage2
An Economic Perspective on the Affordable Care Act: Expectations and Reality2
Levels of Employment and Community Engagement among Low-Income Adults: Implications for Medicaid Work Requirements2
State Regulation and Hospital Community Benefit Spending in Medicaid Expansion States2
Medicare's Stewardship Role to Improve Care Delivery: Opportunities for the Biden Administration2
Undue Burdens: State Abortion Laws in the United States, 1994–20222
What Doctors Want: A Comment on the Financial Preferences of Organized Medicine2
How the Trump Administration's Pandemic Health Care Response Failed Racial Health Equity: Case Studies of Structural Racism and a Call for Equity Mindfulness in Federal Health Policy Making2
Why Did the ACA Co-Op Program Fail? Lessons for the Health Reform Debate2
Pursuing Medicaid Block Grants with the Healthy Adult Opportunity Initiative: Dressing Up Old Ideas in New Clothes2
Comparatively Ineffective? PCORI and the Uphill Battle to Make Evidence Count in US Medicine2
Activism for Abortion Rights and Access Is Global: What the United States Can Learn from the Rest of the World2
Medicare for All—Running Down a Dream2
Centralization vs. Decentralization in COVID-19 Responses: Lessons from China2
Introduction: The Politics of Abortion 50 Years afterRoe2
0.021152019500732